Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

1 records in Main database · 1 status checked

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications	Inspect
Add	CGF166 by Novartis	Novartis	Therapeutic	-	Gene Therapy	Phase 1/2	Completed	Details checkedStatus confirmedHistorical/discontinued	trial · Priority 2	89%	AdultBilateral+1	Hearing LossSensorineural Hearing Loss

Novartis · Gene Therapy · Phase 1/2

CompletedTherapeutic

Evidence

trial

Confidence

89%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultBilateralProfound